Schedule 13G ownership disclosure

Fulcrum Therapeutics Inc

Security class unavailable · CUSIP: 359616109

Event date: 2020-11-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.5500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-20-021235
Form type
SC 13G
Filer
Fulcrum Therapeutics, Inc.
CIK
CIK 1680581
Filed
Nov 13, 2020
Reporting period
Nov 03, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub